TRIF (TICAM1)-mediated TLR4 signaling
Mahita J, Sowdhamini R. Integrative modelling of TIR domain-containing adaptor molecule inducing interferon-ß (TRIF) provides insights into its autoinhibited state. Biology Direct. 2017 Apr 20;12(1):9. doi: 10.1186/s13062-017-0179-0.; Kaiser WJ, Offermann MK. Apoptosis induced by the toll-like receptor adaptor TRIF is dependent on its receptor interacting protein homotypic interaction motif. J Immunol. 2005 Apr 15;174(8):4942–52. doi: 10.4049/jimmunol.174.8.4942. PMID: 15814722.; Han KJ, Su X, Xu LG, Bin LH, Zhang J, Shu HB. Mechanisms of the TRIF-induced interferon-stimulated response element and NF-kappaB activation and apoptosis pathways. J Biol Chem. 2004 Apr 09;279(15):15652–61. doi: 10.1074/jbc.m311629200. PMID: 14739303.; Sato S, Sugiyama M, Yamamoto M, Watanabe Y, Kawai T, Takeda K, Akira S. Toll/IL-1 receptor domain-containing adaptor inducing IFN-beta (TRIF) associates with TNF receptor-associated factor 6 and TANK-binding kinase 1, and activates two distinct transcription factors, NF-kappa B and IFN-regulatory factor-3, in the Toll-like receptor signaling. J Immunol. 2003 Oct 15;171(8):4304–10. doi: 10.4049/jimmunol.171.8.4304. PMID: 14530355.; Fitzgerald KA, Rowe DC, Barnes BJ, Caffrey DR, Visintin A, Latz E, Monks B, Pitha PM, Golenbock DT. LPS-TLR4 signaling to IRF-3/7 and NF-kappaB involves the toll adapters TRAM and TRIF. J Exp Med. 2003 Oct 06;198(7):1043–55. PMID: 14517278; PMCID: PMC2194210.; Yamamoto M, Sato S, Hemmi H, Hoshino K, Kaisho T, Sanjo H, Takeuchi O, Sugiyama M, Okabe M, Takeda K, Akira S. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science. 2003 Aug 01;301(5633):640–3. doi: 10.1126/science.1087262. PMID: 12855817.